Anti-tuberculosis drug development via targeting the cell envelope of Mycobacterium tuberculosis

X Xu, B Dong, L Peng, C Gao, Z He, C Wang… - Frontiers in …, 2022 - frontiersin.org
Mycobacterium tuberculosis possesses a dynamic cell envelope, which consists of a
peptidoglycan layer, a mycolic acid layer, and an arabinogalactan polysaccharide. This …

Target identification in anti-tuberculosis drug discovery

R Capela, R Félix, M Clariano, D Nunes… - International Journal of …, 2023 - mdpi.com
Mycobacterium tuberculosis (Mtb) is the etiological agent of tuberculosis (TB), a disease
that, although preventable and curable, remains a global epidemic due to the emergence of …

Ethambutol and meropenem/clavulanate synergy promotes enhanced extracellular and intracellular killing of Mycobacterium tuberculosis

F Olivença, D Pires, C Silveiro, B Gama… - Antimicrobial Agents …, 2024 - Am Soc Microbiol
Increasing evidence supports the repositioning of beta-lactams for tuberculosis (TB) therapy,
but further research on their interaction with conventional anti-TB agents is still warranted …

Identification of β-Lactams Active against Mycobacterium tuberculosis by a Consortium of Pharmaceutical Companies and Academic Institutions

B Gold, J Zhang, LL Quezada, J Roberts… - ACS infectious …, 2022 - ACS Publications
Rising antimicrobial resistance challenges our ability to combat bacterial infections. The
problem is acute for tuberculosis (TB), the leading cause of death from infection before …

Investigating β-Lactam Drug Targets in Mycobacterium tuberculosis Using Chemical Probes

SR Levine, KE Beatty - ACS infectious diseases, 2021 - ACS Publications
Tuberculosis (TB), caused by the bacterial pathogen Mycobacterium tuberculosis (Mtb),
infects 10 million people a year. An estimated 25% of humans harbor latent TB infections, an …

Cell surface biosynthesis and remodeling pathways in mycobacteria reveal new drug targets

M Shaku, C Ealand, BD Kana - Frontiers in Cellular and Infection …, 2020 - frontiersin.org
Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), remains the
leading cause of death from an infectious bacterium and is responsible for 1.8 million deaths …

Activity-based protein profiling in microbes and the gut microbiome

L Han, PV Chang - Current Opinion in Chemical Biology, 2023 - Elsevier
Activity-based protein profiling (ABPP) is a powerful chemical approach for probing protein
function and enzymatic activity in complex biological systems. This strategy typically utilizes …

Nonredundant functions of Mycobacterium tuberculosis chaperones promote survival under stress

A Harnagel, L Lopez Quezada, SW Park… - Molecular …, 2021 - Wiley Online Library
Abstract Bacterial chaperones ClpB and DnaK, homologs of the respective eukaryotic heat
shock proteins Hsp104 and Hsp70, are essential in the reactivation of toxic protein …

Molecular and microbiological methods for the identification of nonreplicating Mycobacterium tuberculosis

JP Sarathy - Plos Pathogens, 2024 - journals.plos.org
Chronic tuberculosis (TB) disease, which requires months-long chemotherapy with multiple
antibiotics, is defined by diverse pathological manifestations and bacterial phenotypes …

Activity-based probes in pathogenic bacteria: Investigating drug targets and molecule specificity

HK Lembke, EE Carlson - Current opinion in chemical biology, 2023 - Elsevier
Bacteria comprise complex communities within our bodies and largely have beneficial roles,
however a small percentage are pathogenic. While all pathogens are important to public …